I live in Florida, not far from a U.S. Air Force test range. That means we get every type of fighter jet you can think of flying directly over our house. F-4 Phantoms… F-14 Tomcats… F-22 Raptors… F-35 Lightnings… F-22 Raptor We even see V-22 Ospreys every once in a while. Now, I absolutely love […]
There’s no doubt Nvidia (NVDA) will go down as one of the most successful tech stories of the 21st century. For two years, we’ve watched them smash earnings expectations again… and again… and again. At this point, though, the trade is running out of steam. It’s reaching its peak. After all, it’s a $3.5 trillion […]
It’s official. The long winter for Bitcoin is over. America’s first “pro-blockchain” Presidential candidate was elected, and now it’s game on. I don’t think this can be emphasized enough. The President-Elect owns millions in crypto and has launched multiple blockchain projects. His staff is going to be full of pro-crypto participants, and we’re going to […]
I grew up in the ‘90s, back when there was a renaissance for magazines. Zoobooks would come in and you would learn everything about zebras. Boy’s Life had a mail-order section in the back that your mother would always refuse to buy from. And then you had Popular Science. This was the futurist magazine that […]
Taylor Swift just finished up a concert in our area. And just like clockwork, all the millennial moms were scrambling for tickets so they could live vicariously through their daughters. And the prices were nuts. Hundreds of dollars for a ticket, and as the concert got closer, the prices skyrocketed even higher. This is an […]
Imagine you’re sitting in a board meeting for a tech company in Silicon Valley. They’re running out of cash and need to raise capital. Problem is, their B2B SAAS company isn’t getting much traction, and their lead investors don’t want to be involved in another round. So what do you do? You put “AI” in […]
If you’re into biotech stock opportunities, you know the sector has been suppressed lately: XBI, a broad-based biotech ETF That’s due to some macro factors – including the ability to find patients and the costs of the trials. Now that interest rates are starting to ease, it may attract more institutional investment into the space… […]
It was a warm Miami morning, and we were wheels up. I don’t fly private often, but when I do, I will absolutely take a selfie. We were taking the plane 30 minutes north, landing directly inside of Kennedy Space Center (KSC). I was there to run due diligence on a private company that has […]
